Exact Mass: 475.0581

Exact Mass Matches: 475.0581

Found 47 metabolites which its exact mass value is equals to given mass value 475.0581, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Protogonyautoxin I

[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methoxycarbonylsulfamic acid

C10H17N7O11S2 (475.0427)


Gonyautoxin VIII is found in mollusks. Gonyautoxin VIII is from Gonyaulax and Protogonyaulax species. From Gonyaulax and Protogonyaulax subspecies Protogonyautoxin I is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

   
   

Cefovecin sodium

Cefovecin sodium

C17H18N5NaO6S2 (475.0596)


C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   
   
   

Toxin C1

Protogonyautoxin I

C10H17N7O11S2 (475.0427)


D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

   

4-Bromo-N,N-bis(4-methoxybenzyl)benzenesulfonamide

4-Bromo-N,N-bis(4-methoxybenzyl)benzenesulfonamide

C22H22BrNO4S (475.0453)


   
   

N,N-Bis(4-biphenylyl)-N-(4-bromophenyl)amine

N,N-Bis(4-biphenylyl)-N-(4-bromophenyl)amine

C30H22BrN (475.0936)


   

Tegopen

Cloxacillin Sodium

C19H19ClN3NaO6S (475.0581)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

ethyl 5-acetoxy-6-broMo-1-Methyl-2-(p-tolylthioMethyl)-1H-indole-3-carboxylate

ethyl 5-acetoxy-6-broMo-1-Methyl-2-(p-tolylthioMethyl)-1H-indole-3-carboxylate

C22H22BrNO4S (475.0453)


   
   

3-[1-Acetyl-5-(2-furanyl)-3-pyrazolidinylidene]-6-bromo-4-phenyl-2-quinolinone

3-[1-Acetyl-5-(2-furanyl)-3-pyrazolidinylidene]-6-bromo-4-phenyl-2-quinolinone

C24H18BrN3O3 (475.0531)


   

N-(5-{3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]phenyl}-1,3,4-Oxadiazol-2-Yl)ethane-1,2-Diamine

N-(5-{3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]phenyl}-1,3,4-Oxadiazol-2-Yl)ethane-1,2-Diamine

C16H13F3IN5O (475.0117)


   
   

Cytidine-5-diphosphate-glycerol

Cytidine-5-diphosphate-glycerol

C12H19N3O13P2-2 (475.0393)


   

(L-glutamyl)adenylate

(L-glutamyl)adenylate

C15H20N6O10P- (475.0978)


   

N2-[(R)-citryl],N5-[(S)-citryl]-D-ornithine

N2-[(R)-citryl],N5-[(S)-citryl]-D-ornithine

C17H19N2O14-5 (475.0836)


   

flavokermesate-7-C-glucoside

flavokermesate-7-C-glucoside

C22H19O12- (475.0876)


   

Dermatan, 4-(hydrogen sulfate)

Dermatan, 4-(hydrogen sulfate)

C14H21NO15S-2 (475.0632)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents D006401 - Hematologic Agents > D000925 - Anticoagulants

   
   

2-chloro-N-[6-[[(2-chloro-5-nitrophenyl)-oxomethyl]amino]-2-pyridinyl]-5-nitrobenzamide

2-chloro-N-[6-[[(2-chloro-5-nitrophenyl)-oxomethyl]amino]-2-pyridinyl]-5-nitrobenzamide

C19H11Cl2N5O6 (475.0086)


   
   

Chondroitin 4-sulfate anion

Chondroitin 4-sulfate anion

C14H21NO15S-2 (475.0632)


   

alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine

alpha-L-iduronyl-(1->3)-N-acetyl-D-6-sulfogalactosamine

C14H21NO15S-2 (475.0632)


   
   

chondroitin sulfate C anion

chondroitin sulfate C anion

C14H21NO15S-2 (475.0632)


   

Dermatan 6-sulfate anion

Dermatan 6-sulfate anion

C14H21NO15S-2 (475.0632)


   

Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc6S

Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc6S

C14H21NO15S (475.0632)


   

Delta(4)-beta-D-GlcpA-(1->3)-D-GalpNAc4S

Delta(4)-beta-D-GlcpA-(1->3)-D-GalpNAc4S

C14H21NO15S (475.0632)


   

Delta(4)-beta-D-GlcpA-(1->4)-D-GlcpNAc6S

Delta(4)-beta-D-GlcpA-(1->4)-D-GlcpNAc6S

C14H21NO15S (475.0632)


   

Delta(4)-beta-D-GlcpA2S-(1->3)-alpha-D-GlcpNAc

Delta(4)-beta-D-GlcpA2S-(1->3)-alpha-D-GlcpNAc

C14H21NO15S (475.0632)


   

alpha-L-threo-hex-4-enopyranuronosyl-(1->3)-beta-D-GalpNAc6S

alpha-L-threo-hex-4-enopyranuronosyl-(1->3)-beta-D-GalpNAc6S

C14H21NO15S (475.0632)


   

N-[4-[(E)-N-[(4-Bromophenyl)sulfonylamino]-C-methylcarbonimidoyl]phenyl]-5-methylfuran-2-carboxamide

N-[4-[(E)-N-[(4-Bromophenyl)sulfonylamino]-C-methylcarbonimidoyl]phenyl]-5-methylfuran-2-carboxamide

C20H18BrN3O4S (475.0201)


   

2-(Acetylamino)-4-O-[(4,5-didehydro-2-O-sulfo-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

2-(Acetylamino)-4-O-[(4,5-didehydro-2-O-sulfo-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

C14H21NO15S (475.0632)


   

Delta(4)-beta-D-GlcpA-(1->3)-beta-D-GalpNAc4S

Delta(4)-beta-D-GlcpA-(1->3)-beta-D-GalpNAc4S

C14H21NO15S (475.0632)


   

(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO15S (475.0632)


   

(2S,3R,4R)-2-[(2R,3S,4R,5R,6R)-5-Acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2S,3R,4R)-2-[(2R,3S,4R,5R,6R)-5-Acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO15S (475.0632)


   

Protogonyautoxin I

Protogonyautoxin I

C10H17N7O11S2 (475.0427)


D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

   
   

KCC009

KCC009

C21H22BrN3O5 (475.0743)


KCC009, a transglutaminase 2 (TG2) inhibitor, induces p53-independent radiosensitization[1][2].

   

1'-[(2s,3r,4s,5s,6r)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one

1'-[(2s,3r,4s,5s,6r)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one

C22H19Cl2N3O5 (475.0702)


   

1'-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one

1'-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)-5,5'-dichloro-3'-hydroxy-[2,2'-biindol]-3-one

C22H19Cl2N3O5 (475.0702)


   

n-sulfo{[(3as,4r,9r,10as)-10,10-dihydroxy-2,6-diimino-9-(sulfooxy)-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

n-sulfo{[(3as,4r,9r,10as)-10,10-dihydroxy-2,6-diimino-9-(sulfooxy)-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

C10H17N7O11S2 (475.0427)


   

n-sulfo{[(3as,4r,9s,10as)-10,10-dihydroxy-2,6-diimino-9-(sulfooxy)-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

n-sulfo{[(3as,4r,9s,10as)-10,10-dihydroxy-2,6-diimino-9-(sulfooxy)-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

C10H17N7O11S2 (475.0427)